Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease-Reference-Cited by-同舟云学术

Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease

Published:2022-08 Issue: Volume:1262 Page:132979
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Shrivastava Sushant K.,Nivrutti Avhad Ashok,Bhardwaj Bhagwati,Waiker Digambar Kumar,Verma Akash,Tripathi Prabhash Nath,Tripathi Manish,Saraf Poorvi

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference42 articles.

1. 3-Aryl coumarin derivatives bearing aminoalkoxy moiety as multi-target-directed ligands against Alzheimer's disease;Abdshahzadeh;Chem. Biodivers.,2019

2. (−)-Meptazinol–melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy;Cheng;Bioorg. Med. Chem.,2015

3. Damage in Alzheimer's disease brain;Cornett;Neurotoxicology,1998

4. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies;Sharma;Prog. Neurobiol.,2019

5. Treatment combinations for Alzheimer's disease: current and future pharmacotherapy options;Cummings;J. Alzheimers Dis.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of New Highly Potent Histamine H₃ Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors;ACS Chemical Neuroscience;2024-08-29

2. Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer’s disease;3 Biotech;2024-08

3. Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants;Degenerative Neurological and Neuromuscular Disease;2024-05

4. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy;European Journal of Medicinal Chemistry;2024-05

5. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22